rs121909559
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM2_SupportingPP3PP4PP1_StrongPS4_ModeratePM5PM1
This summary comes from the ClinGen Evidence Repository: The c.1246G>C variant in SERPINC1 is a missense variant predicted to cause substitution of alanine by proline at amino acid 416 (p.Ala416Pro). At least one patient with this variant displayed an antithrombin activity level of < 0.8 IU/mL and abnormal crossed electrophoresis, which is highly specific for autosomal dominant hereditary antithrombin deficiency (PP4, PMID:4082101). This variant has been reported in two more probands meeting an antithrombin activity level of < 0.8 IU/mL and a family history of disease with reported decreased antithrombin activity levels (PS4_Moderate; PMID:24583439, 2093312). The variant has been reported to segregate with autosomal dominant hereditary antithrombin deficiency in at least 9 affected meioses from 4 families (PP1_Strong; PMID:33725558, 4082101, 24583439, 2093312).This variant resides within an reactive site residues (Ala416) of SERPINC1 that is defined as a critical functional domain by the ClinGen Thrombosis VCEP (PM1). Another missense variant c.1246G>T (p.Ala416Ser) (ClinVarID:18023) in the same codon has been classified as pathogenic for autosomal dominant hereditary antithrombin deficiency by the ClinGen Thrombosis VCEP (PM5).The computational predictor REVEL gives a score of 0.837, which is above the threshold of 0.6, evidence that correlates with impact to SERPINC1 function (PP3). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria to be classified as pathogenic forautosomal dominant hereditary antithrombin deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Thrombosis VCEP: PP1_strong, PM1, PM5, PS4_moderate, PP3, PP4, PM2_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA210750/MONDO:0013144/084
Frequency
Consequence
NM_000488.4 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary antithrombin deficiencyInheritance: AD, AR, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000488.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SERPINC1 | MANE Select | c.1246G>C | p.Ala416Pro | missense | Exon 7 of 7 | NP_000479.1 | P01008 | ||
| SERPINC1 | c.1369G>C | p.Ala457Pro | missense | Exon 7 of 7 | NP_001373231.1 | ||||
| SERPINC1 | c.1327G>C | p.Ala443Pro | missense | Exon 8 of 8 | NP_001373232.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SERPINC1 | TSL:1 MANE Select | c.1246G>C | p.Ala416Pro | missense | Exon 7 of 7 | ENSP00000356671.3 | P01008 | ||
| SERPINC1 | c.1375G>C | p.Ala459Pro | missense | Exon 7 of 7 | ENSP00000544387.1 | ||||
| SERPINC1 | c.1369G>C | p.Ala457Pro | missense | Exon 7 of 7 | ENSP00000544383.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at